Epitome Pharmaceuticals

Epitome Pharmaceuticals Advances Drug Development. For its drugs, Epitome Pharmaceuticals clarifies regulatory issues through close collaboration with regulatory authorities. Based on its research and the prospects of specific drugs, Epitome Pharmaceuticals can submit an IND and initiate Phase I or Phase II trials. Subsequently, Epitome Pharmaceuticals licenses its intellectual property to partners whose resources and capabilities can complete clinical trials, obtain regulatory approval, and bring the product to market most efficiently.